WHY KETAMINE THERAPY IS ON THE RISE IN THE AUSTRALIAN CAPITAL TERRITORY

Mental health treatment in the Australian Capital Territory (ACT) is undergoing a transformation. Traditional methods—while effective for many—have not always offered timely relief for people living with treatment-resistant conditions like depression, anxiety, PTSD, and chronic pain. This shortfall has led to growing interest in alternative therapies. One of the most promising options now gaining traction is ketamine therapy.
But why is ketamine therapy seeing such an increase in demand in the ACT? And what do patients need to know before starting treatment? In this guide, we explore the science, the local access points, and the real-world impact of ketamine in Canberra and the wider ACT.
UNDERSTANDING KETAMINE: FROM ANAESTHETIC TO ANTIDEPRESSANT
Ketamine has long been used as an anaesthetic in hospitals and veterinary clinics. However, its application in mental health began gaining attention after researchers discovered its powerful antidepressant effects at low doses. Unlike standard SSRIs, which act on serotonin and can take weeks to work, ketamine interacts with the brain’s glutamate system and can begin improving symptoms within hours.
This fast-acting quality makes it especially valuable for individuals at high risk of suicide or those whose conditions have not responded to traditional treatments.
HOW KETAMINE THERAPY WORKS
In the ACT, ketamine is generally administered in one of three ways:
- Intravenous (IV) infusions
- Intramuscular injections
- Lozenge (oral) or nasal spray (S-ketamine)
Most clinics in Canberra and surrounding areas use IV infusion due to its precision and safety. The procedure typically involves:
- A full psychiatric assessment
- A series of ketamine infusions administered over two to three weeks
- Supervision by a medical professional during treatment
- Follow-up support, often with psychotherapy or integration counselling
WHY INTEREST IS GROWING IN THE ACT
Several factors are contributing to the rise of ketamine therapy in the Australian Capital Territory.
1. GROWING MENTAL HEALTH NEEDS
According to ACT Health statistics, rates of anxiety and depression have steadily increased over the last decade. The pandemic, climate anxiety, and social isolation have only worsened these trends. Unfortunately, access to psychiatric services has not always kept pace with demand.
Many patients in Canberra report long wait times to see mental health professionals. For those who can’t wait, ketamine offers a rapid intervention option that doesn’t rely on month-long waiting periods or trial-and-error prescribing.
2. HIGH RATES OF TREATMENT-RESISTANT CONDITIONS
Roughly 30% of people with depression do not respond to two or more types of antidepressants. These individuals are considered “treatment-resistant.” For them, ketamine may be one of the only available alternatives.
Additionally, those with PTSD, OCD, or bipolar depression have seen remarkable improvements in clinical trials involving ketamine infusions.
3. SUPPORT FROM THE SCIENTIFIC COMMUNITY
Research from Australian universities and international bodies continues to validate ketamine’s efficacy. ACT residents are paying attention. They are increasingly turning to medically-supervised clinics offering this innovative treatment.
Moreover, local GPs and psychiatrists are beginning to refer patients for ketamine therapy as part of a broader treatment plan.
CONDITIONS KETAMINE THERAPY CAN HELP ADDRESS
The flexibility of ketamine’s mechanism of action makes it useful for a range of mental health and pain conditions. In the ACT, patients most often seek treatment for the following:
DEPRESSION
Ketamine’s rapid effects on mood make it a game-changer for people who haven’t found relief from traditional antidepressants. It encourages synaptic growth and neuroplasticity, helping the brain develop new, healthier patterns of thought.
PTSD
People suffering from post-traumatic stress disorder often struggle with nightmares, flashbacks, and emotional numbness. Ketamine helps reduce the emotional charge of traumatic memories, making trauma therapy more effective.
ANXIETY DISORDERS
Chronic anxiety can result in racing thoughts, panic attacks, and social withdrawal. Ketamine infusions can provide a sense of calm and reduce the hyperactivity seen in the anxious brain.
CHRONIC PAIN CONDITIONS
Ketamine also functions as an NMDA receptor antagonist, which makes it useful in treating neuropathic pain. In Canberra, patients with fibromyalgia or CRPS (complex regional pain syndrome) have begun exploring this option.
WHERE TO ACCESS KETAMINE THERAPY IN THE ACT
Canberra is home to a growing number of clinics offering ketamine infusions, often as part of a multidisciplinary approach. These clinics typically provide:
- Comprehensive psychiatric evaluations
- A treatment plan that includes ketamine infusions
- Monitoring by trained professionals
- Integration services like counselling or psychotherapy
Patients usually require a referral from a general practitioner or psychiatrist to begin treatment.
Some facilities also offer telehealth services for follow-ups, which makes the treatment process more convenient.
WHAT TO EXPECT DURING TREATMENT
Many patients are unsure of what ketamine therapy involves. Here’s what typically happens in a controlled setting:
BEFORE YOUR INFUSION
You’ll undergo a full assessment to rule out contraindications such as schizophrenia, uncontrolled high blood pressure, or active substance abuse. If approved, your treatment plan will be scheduled.
DURING THE INFUSION
A ketamine infusion usually takes 40–60 minutes. During this time, you may experience:
- Visual or auditory distortions
- A sense of detachment or dissociation
- Emotional breakthroughs
Medical staff are always present to ensure safety and support.
AFTER THE INFUSION
Patients are monitored for 30–60 minutes post-treatment. While most people feel tired, many report feeling “lighter,” more open, or less burdened by their symptoms.
SAFETY AND SIDE EFFECTS
Ketamine is safe when used under supervision, but it’s not without risks. Short-term side effects may include:
- Dizziness or nausea
- Blurred vision
- Increased blood pressure
- Disorientation
These effects usually fade within a few hours. Importantly, no long-term cognitive side effects have been reported with the controlled, intermittent use seen in therapeutic settings.
COST AND FUNDING OPTIONS IN THE ACT
One barrier to ketamine therapy is the cost. Most treatments are not yet covered by Medicare unless the patient is receiving S-ketamine (esketamine) under the PBS (Pharmaceutical Benefits Scheme).
PRICING ESTIMATES:
- IV ketamine infusion: $400–$800 per session
- Esketamine nasal spray: Covered partially under PBS, but with eligibility restrictions
- Consultation and integration sessions: Often billed separately
Some private health insurers may reimburse part of the cost, especially for chronic pain treatment. However, most patients in Canberra are currently paying out of pocket.
PATIENT STORIES FROM CANBERRA AND BEYOND
Personal accounts offer a glimpse into the real-world benefits of ketamine therapy. Many Canberra residents have reported profound improvements.
Emily, a public servant with a long history of depression, said, “I was running out of options. Ketamine gave me back my motivation and sense of purpose.” She now works with a therapist to build on her treatment gains.
Marcus, a defence veteran, found relief from PTSD after years of failed treatments. “The infusions made the trauma feel manageable for the first time,” he shared.
These testimonials are encouraging others to look beyond traditional methods.
THE FUTURE OF KETAMINE IN MENTAL HEALTH
As Australia—and the ACT in particular—begins to embrace psychedelic-assisted therapies, ketamine is leading the charge. The Therapeutic Goods Administration (TGA) is considering expanded access to psychedelic therapies, and ketamine’s safety profile makes it a natural candidate.
LIKELY FUTURE DEVELOPMENTS INCLUDE:
- More clinics opening in Canberra and Queanbeyan
- Expansion of eligibility under the PBS
- Increased training for mental health professionals
- Improved integration with telepsychiatry and therapy services
The ACT is already home to a forward-thinking healthcare community. With the right regulatory and clinical support, ketamine therapy could become a core part of the mental health toolkit.
FINAL THOUGHTS
The rise of ketamine therapy in the Australian Capital Territory is more than a trend—it’s a response to a real, unmet need. With growing research support, rising local demand, and increasing numbers of providers, ketamine is changing lives.
If you or a loved one has struggled with persistent depression, PTSD, or anxiety, and traditional methods haven’t helped, ketamine therapy might offer a new path forward.
Always speak with your doctor or mental health provider to explore whether this approach is suitable for you.
